Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. China announced on Thursday it would immediately restrict Hollywood film imports in retaliation for President Donald Trump‘s tariff increases on Chinese goods, targeting a high-profile American export as trade tensions intensify. What Happened: A spokesperson for the National Film Administration said, “The wrong move by the U.S. government to abuse tariffs on China will inevitably further reduce the domestic audience’s favorability towards American films. We will follow market rules, respect the audience’s choice, and moderately reduce the number of American films imported.” Don’t Miss: Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share! The move could significantly impact major U.S. studios and entertainment companies with Chinese market exposure. IMAX Corp (NYSE:IMAX) faces particular exposure with 23% of its revenue derived from China, where 45% of all IMAX screens are located. Despite this, the company recently reported strong performance in China during 2025’s first quarter, driven primarily by the domestic blockbuster “Ne Zha 2.” “IMAX is benefiting from a blockbuster-heavy 2025-2026 slate and tighter cost control, especially in China,” noted Rosenblatt Securities analyst Steve Frankel, who maintains a “Buy” rating on the stock. See Also: The $1.3 billion startup investment boom: How this company's explosive growth is opening doors for everyday investors with a new $500 minimum Why It Matters: Walt Disney Co (NYSE:DIS) and Warner Bros Discovery Inc (NASDAQ:WBD) also face potential impacts. Disney’s Marvel superhero movie “Thunderbolts” secured permission to debut in China on Apr. 30, but the fate of other summer blockbusters remains uncertain. WBD’s stock has already fallen 21.80% over the last month amid these concerns. The restrictions follow Beijing’s broader retaliation against Washington’s tariff hikes, which includes increasing its levies on U.S. goods from 34% to 84% and filing a World Trade Organization complaint. Two influential Chinese bloggers with Communist Party connections recently suggested China would “reduce or ban the import of U.S.-made films” along with restricting American companies from government procurement processes. For U.S. studios, the $600 million earned in China last year represents a small but strategic portion of their global revenue. However, China’s growing preference for domestic content had already created challenges for Hollywood before these new restrictions. Story Continues Read Next: Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today. SmartAsset’s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. Arrived Home's Private Credit Fund’s has historically paid an annualized dividend yield of 8.1%*, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum. Image via Shutterstock Send To MSN: Send to MSN This article Hollywood Becomes Collateral Damage In Trump Tariff War As China Slashes Film Imports, Says US Actions Will Inevitably Reduce 'Favorability' Towards American Films originally appeared on Benzinga.com View Comments
Hollywood Becomes Collateral Damage In Trump Tariff War As China Slashes Film Imports, Says US Actions Will Inevitably Reduce 'Favorability' Towards American Films
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...